Gene · 2358
Papers3,281
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 3,281
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Exploring the shared gene signatures between rheumatoid arthritis and type 2 diabetes and their implication for drug repositioning on bioinformatics analysis. | Medicine (Baltimore) | 2026 | 41760032 | PubTator, text mining | PubMed |
| Mechanistic machine learning enables interpretable and generalizable prediction of prime editing outcomes. | bioRxiv | 2026 | 41757025 | PubTator, text mining | PubMed |
| The Analgesic Effects of Nrf2 Activators in Chemotherapy-Induced Neuropathic Pain: Evidence from Animal Studies and Consequences for Translation into Clinical Trials. | Int J Mol Sci | 2026 | 41751884 | PubTator, text mining | PubMed |
| Host Defense Antimicrobial Peptides (HDPs) as Regulators of Hemostasis and Vascular Biology. | Biomolecules | 2026 | 41750290 | PubTator, text mining | PubMed |
| Pro- and Anti-Inflammatory Cytokines' Implication in Right Heart Disease, Arrhythmogenesis, and Atrial Fibrillation. | Biomolecules | 2026 | 41750286 | PubTator, text mining | PubMed |
| Precise Mapping of the Proteasome Interaction Region (PIR) of p62/SQSTM1: Decoupling Condensate Formation from Proteasome Recruitment. | Cells | 2026 | 41744778 | PubTator, text mining | PubMed |
| Extracellular vesicles in rheumatoid arthritis: emerging roles in progression, diagnosis, and therapeutic development. | Front Immunol | 2026 | 41743711 | PubTator, text mining | PubMed |
| Role of trained immunity in DCs and macrophages in the induction of Th2 responses and allergy treatment. What do we know? | Front Immunol | 2026 | 41727488 | PubTator, text mining | PubMed |
| Research progress on the influence of tumor microenvironment on immunotherapy for pancreatic ductal adenocarcinoma. | Open Med (Wars) | 2026 | 41726142 | PubTator, text mining | PubMed |
| Annexin A1 exacerbates islet stellate cell activation by regulating triglyceride catabolism via the PPARα/ACOX1/CYP4a pathway. | Islets | 2026 | 41723748 | PubTator, text mining | PubMed |
| Macrophage polarisation under immune regulation as a therapeutic target for tendon-bone healing: multifactorial regulation and mechanistic insights. | Front Immunol | 2026 | 41710885 | PubTator, text mining | PubMed |
| From Lead to Clinical Candidate: Discovery of BMS-986331 as a Potent and Selective N-Formyl Peptide Receptor 2 Agonist. | J Med Chem | 2026 | 41701653 | PubTator, text mining | PubMed |
Integrative cross-tissue and spatially resolved single-cell profiling uncovers tumour-educated inflammatory remodelling of tissue-resident macrophage ecosystem with immunotherapeutic prognostic significance in pan-cancer. | Clin Transl Med | 2026 | 41655028 | PubTator, text mining | PubMed |
| Hepatocytes functionally reprogrammed by KIAA1199-high colorectal cancer cells favour the accumulation of pro-metastatic Egr1+ neutrophils. | Nat Commun | 2026 | 41654488 | PubTator, text mining | PubMed |
| Formyl peptide receptor 2 activation by MR-39 inhibits glioblastoma cell proliferation and invasiveness through suppression of multiple oncogenic pathways. | J Transl Med | 2026 | 41652630 | PubTator, text mining | PubMed |
| From brain to eye: Annexin A1 and A2 as a key mediator of retinal neuroinflammation in Parkinson's and Alzheimer's disease. | Int J Retina Vitreous | 2026 | 41639875 | PubTator, text mining | PubMed |
| Expression of key genes in IVIG-unresponsive Kawasaki disease and their immune correlation based on bioinformatics analysis. | Immunol Res | 2026 | 41575683 | PubTator, text mining | PubMed |
| Emerging frontiers in the mitochondrial regulation of dendritic cell biology. | Redox Biol | 2026 | 41564795 | PubTator, text mining | PubMed |
| A small molecule VDAC ligand inhibits ERAD and induces selective cancer cell death via disruption of calcium homeostasis. | Nat Commun | 2026 | 41547848 | PubTator, text mining | PubMed |
| <p>Unveiling sex differences in pancreatic ductal adenocarcinoma: Current evidence and future directions (Review)</p>. | Int J Oncol | 2026 | 41543183 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2358/papers?page=3